CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Treating treatment-naïve Genotype 1 (G1) chronic Hepatitis C (CHC) patients with dual (Peginterferon/Ribavirin, P/R) or triple (P/R + Protease Inhibitor, PI) therapy in Hungary. An approach with limited financial resources
DOI 10.1055/s-0032-1312386
Bibliografische Angaben
Nachweis in CareLit
Autor:innenB Hunyady, M Makara, J Gervain, G Horváth, F Szalay, I Tornai
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe05/2012
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Introduction of protease inhibitors for the treatment of CHC poses new challenges in countries with limited resources. Cost-effectiveness analysis may provide acceptable compromises for both patients and payers. Aims: To analyse the hypothesis that, initial SOC dual therapy for all naïve G1 CHC patients with an early switch to triple therapy for those with low chance of SVR based on on-treatment viral re…
Zitieren
Zitierempfehlung
B Hunyady, M Makara, J Gervain, G Horváth, F Szalay, I Tornai (2012) Treating treatment-naïve Genotype 1 (G1) chronic Hepatitis C (CHC) patients with dual (Peginterferon/Ribavirin, P/R) or triple (P/R + Protease Inhibitor, PI) therapy in Hungary. An approach with limited financial resources. Zeitschrift für Gastroenterologie (05). https://doi.org/10.1055/s-0032-1312386
Mit CareLit weiterarbeiten